AFB-Antibiogram for MTb complex Ofloxacin

AFB-Antibiogram for MTb Complex – Ofloxacin

Sample Type: AFB Culture Isolate (Mycobacterium tuberculosis complex)

Test Overview

The AFB-Antibiogram for MTb Complex – Ofloxacin determines whether Mycobacterium tuberculosis (MTB) is susceptible or resistant to Ofloxacin, a fluoroquinolone antibiotic. This test helps clinicians select the most effective treatment regimen, particularly in cases of drug-resistant tuberculosis (TB).

Why is this Test Done?

• Detect resistance to Ofloxacin in MTB isolates.
• Guide appropriate anti-tuberculosis therapy.
• Support the diagnosis and management of multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) cases.
• Monitor drug susceptibility for individualized treatment planning.

When is it Recommended?

• Confirmed MTB culture-positive patients.
• Suspected or confirmed drug-resistant TB.
• Patients with previous TB treatment failure or relapse.
• Individuals not responding adequately to standard TB therapy.

Interpretation

• Susceptible: The MTB isolate is likely to respond to Ofloxacin treatment.
• Resistant: The MTB isolate is unlikely to respond to Ofloxacin, and alternative medications may be required.

Benefits

• Helps optimize TB treatment.
• Supports early detection of drug resistance.
• Reduces the risk of treatment failure and disease transmission.
• Assists physicians in choosing effective second-line therapies.

Note: Test results should always be interpreted by a qualified physician along with clinical findings, patient history, and other microbiological investigations.